Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients.
Repository Usage Stats
Pulmonary and/or tricuspid valve dysfunction is common among individuals with congenital heart disease, and surgical intervention often carries prohibitive risks. Transcatheter valve replacement (TVR) of the right-sided cardiac valves has become a viable treatment option over the past two decades, while continued technological development aims to broaden its applicability to an even larger portion of those with repaired congenital heart disease. To date, two transcatheter valves have been approved for use in patients with dysfunctional right ventricular to pulmonary artery conduits as well as those with failing pulmonic bioprosthetic valves, and are also used off-label in the "native" RVOT and within surgically repaired/replaced but failing tricuspid valves. TVR has demonstrated comparable safety and short-term outcomes to that of surgical valve replacement. This article aims to review current available devices, focusing on their safety, efficacy and on and off label usage, while briefly describing some of the emerging devices and novel procedural techniques that will likely lead to significant expansion of transcatheter treatment of right sided valve disease in the future.
Heart Defects, Congenital
Heart Valve Diseases
Heart Valve Prosthesis Implantation
Heart Valve Prosthesis
Published Version (Please cite this version)10.1016/j.pcad.2018.09.003
Publication InfoFleming, Gregory; Krasuski, Richard; & Gales, Jordan (2018). Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients. Progress in cardiovascular diseases, 61(3-4). pp. 347-359. 10.1016/j.pcad.2018.09.003. Retrieved from https://hdl.handle.net/10161/17933.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Associate Professor of Pediatrics
Clinical interests include pediatric interventional cardiac catheterization and treatment of infants and children with acquired and congenital heart disease. Research interests include assessment and development of interventional therapies for children with congenital heart disease, and perioperative management of infants and children with congenital heart disease requiring surgery.
Professor of Medicine
Alphabetical list of authors with Scholars@Duke profiles.
Showing items related by title, author, creator, and subject.
Neurological injury after transcatheter aortic valve implantation: are the trees falling silently or is our hearing impaired? Browndyke, Jeffrey Nicholas; Mathew, Joseph P (Circ Cardiovasc Interv, 2013-12)
Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish. Gemberling, M; Karra, R; Dickson, AL; Poss, KD (Elife, 2015-04-01)Heart regeneration is limited in adult mammals but occurs naturally in adult zebrafish through the activation of cardiomyocyte division. Several components of the cardiac injury microenvironment have been identified, yet ...
Two Cases of Late Shone Syndrome With Pulmonary Hypertension: Heart-Lung Transplant or Valve Surgery? Blackstone, Eugene H; Hanna, M; Krasuski, Richard Andrew; Pettersson, Gosta B; Robich, MP; Stewart, RD; Zahka, KG (World J Pediatr Congenit Heart Surg, 2016-01)Two cases of Shone syndrome with severe mitral and aortic valve problems and pulmonary hypertension were referred for heart-lung transplantation. Severely elevated pulmonary vascular resistance (PVR) was confirmed as was ...